'Alternative history' of the NIH shows how a 40% budget cut may thwart new medicines
A new study by professors
A new study by professors
A new study found that more than half of drugs approved by the FDA since 2000 used NIH-fun
Many economists believe claims by CEOs and the tech industry are — at least on an economy-wide level — overblown.
A study by senior lecturer Robert Pozen and co-authors found that in Britain, the shift t
All the LLMs — which are infamously sycophantic — tweaked their answers when questions hinted at a user's demographics or political affiliation.
Assistant professor Chara Podimata co-authored a recent
A study by principal research scientist
In this Lean Blog Interviews podcast episode, professor Nelson Repenning shares
Studies of the economic impacts of climate change often look at long-term, national costs.
At a Bitcoin focused event this month research scientist Christian Catalini made the case